Drug Information

Drug General Information
Drug ID
D06KUY
Former ID
DIB014264
Drug Name
ACH-2684
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 1 [549256]
Company
Achillion pharmaceuticals
Structure
Download
2D MOL
Formula
C45H56F2N6O8S2
Canonical SMILES
COc1ccc2c(O[C@@H]3C[C@@H]4N(C3)C(=O)[C@@H](CC(=O)N5CCCC<br />(F)(F)C5)CCCCC\\C=C/[C@@H]6C[C@]6(NC4=O)C(=O)NS(=O)(=O)<br />C7CC7)cc(nc2c1C)c8nc(cs8)C(C)C
InChI
1S/C45H56F2N6O8S2/c1-26(2)34-24-62-41(49-34)33-21-37(32-15-16-36(60-4)27(3)39(32)48-33)61-30-20-35-40(55)50-45(43(57)51-63(58,59)31-13-14-31)22-29(45)12-9-7-5-6-8-11-28(42(56)53(35)23-30)19-38(54)52-18-10-17-44(46,47)25-52/h9,12,15-16,21,24,26,28-31,35H,5-8,10-11,13-14,17-20,22-23,25H2,1-4H3,(H,50,55)(H,51,57)/b12-9-/t28-,29-,30-,35+,45-/m1/s1
InChIKey
UDMJANYPQWEDFT-ZAWFUYGJSA-N
PubChem Compound ID
56935739
Target and Pathway
Target(s) Nonstructural protein NS3 Target Info Modulator [1572591]
References
Ref 549256Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800034265)
Ref 1572591Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.